Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore what makes the best high yield dividend ETF for retirees, focusing on yield stability, fees, and diversification. This quick intro helps you compare options.
26,985 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Volatility tests reshape the defensive playbook in consumer staples. Coca-Cola edges ahead of PepsiCo on cash flow an...
As Republic Services reveals Q1 2026 figures, investors gain a window into revenue growth, margins, and cash flow. Th...
Investors rally around earnings season, but the big question remains: should abbott labs stock be part of your plan b...
Oil jumped sharply in March 2026, but USOI investors faced capped upside and ongoing credit risk. The piece explains ...
A midstream-focused energy ETF aims to deliver reliable income through toll-road style fees rather than volatile comm...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
As markets wobble in 2026, the decision on when claiming social security remains critical. Early claims can help cash...
PBDC, a focused BDC ETF, slashed its April 2026 payout by about 14% to $0.71273 per share. With shares near $27 and a...
As money flows into SPY accelerate, four small-cap ETFs are quietly delivering outsized gains. This report breaks dow...
As market conditions shift in 2026, VFIAX remains a top pick for buy-and-hold strategies. The fund combines a low 0.0...
A looming major social security deadline could reshape retirement planning. This article explains what it is, why it ...